Cochrane Abstracts
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review. Accessed November 11, 2025.
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
Direct Thrombin Inhibitors Versus Vitamin K Antagonists or Low Molecular Weight Heparins for Prevention of Venous Thromboembolism Following Total Hip or Knee Replacement [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 November 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
ID - 439783
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439783/all/Direct_thrombin_inhibitors_versus_vitamin_K_antagonists_or_low_molecular_weight_heparins_for_prevention_of_venous_thromboembolism_following_total_hip_or_knee_replacement:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
